All Stories

  1. Unveiling of promising DprE1 inhibitor hits from our designed virtual library and Africa natural products database through integrated computational approaches

    Article • Scientific African, June 2026, Elsevier

    Mr CONRAD SIMOBEN VERANSO

  2. The Pan-African Natural Products Library Compounds Oleanolic Acid, Poinsettifolin B, and Rhuschalcone III Disrupt SARS-CoV-2 Spike-Host ACE2 Interactions and SARS-CoV-2 Replication

    Article • February 2026, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  3. Enantioselective protein affinity selection mass spectrometry (E-ASMS)

    Article • Nature Communications, December 2025, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO, Dr Andreas C Joerger

  4. Identification and Characterization of a Small Molecule Ligand for the Huntingtin-HAP40 Complex

    Article • November 2025, openRxiv

    Mr CONRAD SIMOBEN VERANSO

  5. African Natural Products Database (ANPDB): A resource for exploring the therapeutic potential of natural compounds from Africa

    Article • Nucleic Acids Research, November 2025, Oxford University Press (OUP)

    Dr Smith B. Babiaka, Humboldt Fellow, Mr CONRAD SIMOBEN VERANSO, Dr. Aurélien F. A. Moumbock

  6. Iboga‐Indole Alkaloids as Potential Plasmodial Inhibitors: Identification, Biosynthesis, and Molecular Docking Studies

    Article • Chemistry & Biodiversity, October 2025, Wiley

    Dr Smith B. Babiaka, Humboldt Fellow, Mr CONRAD SIMOBEN VERANSO

  7. Natural Products in Cyperus Species (Cyperaceae): Phytochemistry, Pharmacological Activities, and Biosynthesis

    Article • Chemistry & Biodiversity, April 2025, Wiley

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  8. StreptomeDB 4.0: a comprehensive database of streptomycetes natural products enriched with protein interactions and interactive spectral visualization

    Article • Nucleic Acids Research, November 2024, Oxford University Press (OUP)

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow, Dr. Aurélien F. A. Moumbock

  9. Computational discovery of dual potential inhibitors of SARS‐CoV‐2 spike/ACE2 and Mpro: 3D-pharmacophore, docking-based virtual screening, quantum mechanics and molecular dynamics

    Article • European Biophysics Journal, June 2024, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO

  10. Emerging structure-based computational methods to screen the exploding accessible chemical space

    Article • Current Opinion in Structural Biology, June 2024, Elsevier

    Mr CONRAD SIMOBEN VERANSO

  11. 5-chloro-3-(2-(2,4-dinitrophenyl) hydrazono)indolin-2-one: synthesis, characterization, biochemical and computational screening against SARS-CoV-2

    Article • Chemical Papers, March 2024, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO

  12. Design, synthesis, and biochemical and computational screening of novel oxindole derivatives as inhibitors of Aurora A kinase and SARS-CoV-2 spike/host ACE2 interaction

    Article • Medicinal Chemistry Research, March 2024, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO

  13. Challenges in natural product-based drug discovery assisted with in silico-based methods

    Article • RSC Advances, January 2023, Royal Society of Chemistry

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow, Dr. Aurélien F. A. Moumbock

  14. Artificial intelligence for antiviral drug discovery in low resourced settings: A perspective

    Article • Frontiers in Drug Discovery, November 2022, Frontiers

    Mr CONRAD SIMOBEN VERANSO

  15. Synthesis, structure-activity relationships, cocrystallization and cellular characterization of novel smHDAC8 inhibitors for the treatment of schistosomiasis

    Article • European Journal of Medicinal Chemistry, December 2021, Elsevier

    Mr CONRAD SIMOBEN VERANSO

  16. 11 Case studies on computer-based identification of natural products as lead molecules

    Article • November 2021, De Gruyter

    Mr CONRAD SIMOBEN VERANSO

  17. Binding Free Energy (BFE) Calculations and Quantitative Structure–Activity Relationship (QSAR) Analysis of Schistosoma mansoni Histone Deacetylase 8 (smHDAC8) Inhibitors

    Article • Molecules, April 2021, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  18. Strategies To Design Selective Histone Deacetylase Inhibitors

    Article • ChemMedChem, February 2021, Wiley

    Mr CONRAD SIMOBEN VERANSO

  19. Alkaloids with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling

    Article • Molecules, December 2020, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  20. Compounds with Anti-Onchocercal Activity from Voacanga africana Stapf (Apocynaceae): Identification and Molecular Modeling

    Article • November 2020, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  21. StreptomeDB 3.0: an updated compendium of streptomycetes natural products

    Article • Nucleic Acids Research, October 2020, Oxford University Press (OUP)

    Dr. Aurélien F. A. Moumbock, Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  22. Pharmacoinformatic Investigation of Medicinal Plants from East Africa

    Article • Molecular Informatics, October 2020, Wiley

    Dr. Aurélien F. A. Moumbock, Mr CONRAD SIMOBEN VERANSO

  23. Novel Histone Deacetylase Inhibitors and HIV-1 Latency-Reversing Agents Identified by Large-Scale Virtual Screening

    Article • Frontiers in Pharmacology, June 2020, Frontiers

    Mr CONRAD SIMOBEN VERANSO

  24. Case studies on computer-based identification of natural products as lead molecules

    Article • Physical Sciences Reviews, May 2020, De Gruyter

    Mr CONRAD SIMOBEN VERANSO, Prof. Dr. Fidele Ntie-Kang

  25. Synthesis, Urease Inhibition and Molecular Modelling Studies of Novel Derivatives of the Naturally Occurring β-Amyrenone

    Article • Natural Products and Bioprospecting, November 2018, Springer Science + Business Media

    Prof Jean Jules Bankeu Kezetas, Mr CONRAD SIMOBEN VERANSO

  26. Design of selective histone deacetylase inhibitors: rethinking classical pharmacophore

    Article • Future Medicinal Chemistry, July 2018, Future Science

    Mr CONRAD SIMOBEN VERANSO

  27. Compounds from African Medicinal Plants with Activities Against Selected Parasitic Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis

    Article • Natural Products and Bioprospecting, May 2018, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO

  28. A Novel Class of Schistosoma mansoni Histone Deacetylase 8 (HDAC8) Inhibitors Identified by Structure-Based Virtual Screening and In Vitro Testing

    Article • Molecules, March 2018, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  29. In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV properties

    Article • Computational Biology and Chemistry, February 2018, Elsevier

    Mr CONRAD SIMOBEN VERANSO

  30. Compounds from African Medicinal Plants with Activities against Protozoal Diseases: Schistosomiasis, Trypanosomiasis and Leishmaniasis

    Article • January 2018, MDPI AG

    Mr CONRAD SIMOBEN VERANSO

  31. Computational Studies and Biosynthesis of Natural Products with Promising Anticancer Properties

    Article • July 2017, IntechOpen

    Mr CONRAD SIMOBEN VERANSO, Dr. Aurélien F. A. Moumbock

  32. NANPDB: A Resource for Natural Products from Northern African Sources

    Article • Journal of Natural Products, June 2017, American Chemical Society (ACS)

    Mr CONRAD SIMOBEN VERANSO, Dr. Aurélien F. A. Moumbock

  33. African Medicinal Plants: An Untapped Reservoir of Potential Anticancer Agents

    Article • May 2017, Bentham Science Publishers

    Mr CONRAD SIMOBEN VERANSO

  34. Pharmacophore modeling and in silico toxicity assessment of potential anticancer agents from African medicinal plants

    Article • Drug Design Development and Therapy, July 2016, Dove Medical Press

    Prof. Dr. Fidele Ntie-Kang, Mr CONRAD SIMOBEN VERANSO, Berin Karaman Mayack

  35. 11th German Conference on Chemoinformatics (GCC 2015)

    Article • Journal of Cheminformatics, April 2016, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO

  36. Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part II: Alkaloids, Terpenoids and Flavonoids

    Article • Anti-Cancer Agents in Medicinal Chemistry, November 2015, Bentham Science Publishers

    Prof. Dr. Fidele Ntie-Kang, Mr CONRAD SIMOBEN VERANSO

  37. Exploring Cancer Therapeutics with Natural Products from African Medicinal Plants, Part I: Xanthones, Quinones, Steroids, Coumarins, Phenolics and other Classes of Compounds

    Article • Anti-Cancer Agents in Medicinal Chemistry, September 2015, Bentham Science Publishers

    Prof. Dr. Fidele Ntie-Kang, Mr CONRAD SIMOBEN VERANSO

  38. ChemInform Abstract: The Uniqueness and Therapeutic Value of Natural Products from West African Medicinal Plants. Part 3. Least Abundant Compound Classes

    Article • ChemInform, November 2014, Wiley

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  39. ChemInform Abstract: The Uniqueness and Therapeutic Value of Natural Products from West African Medicinal Plants. Part 2. Terpenoids, Geographical Distribution and Drug Discovery

    Article • ChemInform, November 2014, Wiley

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  40. ChemInform Abstract: The Uniqueness and Therapeutic Value of Natural Products from West African Medicinal Plants. Part 1. Uniqueness and Chemotaxonomy

    Article • ChemInform, October 2014, Wiley

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  41. Molecular Modeling of Potential Anticancer Agents from African Medicinal Plants

    Article • Journal of Chemical Information and Modeling, September 2014, American Chemical Society (ACS)

    Mr CONRAD SIMOBEN VERANSO

  42. A Bioactivity Versus Ethnobotanical Survey of Medicinal Plants from Nigeria, West Africa

    Article • Natural Products and Bioprospecting, February 2014, Springer Science + Business Media

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  43. The uniqueness and therapeutic value of natural products from West African medicinal plants. Part I: uniqueness and chemotaxonomy

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Mr CONRAD SIMOBEN VERANSO, Dr Smith B. Babiaka, Humboldt Fellow

  44. The uniqueness and therapeutic value of natural products from West African medicinal plants, part II: terpenoids, geographical distribution and drug discovery

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Mr CONRAD SIMOBEN VERANSO

  45. The uniqueness and therapeutic value of natural products from West African medicinal plants, part III: least abundant compound classes

    Article • RSC Advances, January 2014, Royal Society of Chemistry

    Prof. Dr. Fidele Ntie-Kang, Mr CONRAD SIMOBEN VERANSO